In the current critical review we discuss these emerging trends in localized and systemic treatment as well as possible interesting combinations of the two modalities. Finally, we discuss the role of the new systemic agents in non–clear cell RCC.
Ronald D. Ennis, MD
Advertisement
Articles by Ronald D. Ennis, MD
Advertisement
Latest Updated Articles
- Integrating Innovative Therapeutic Strategies Into the Management of Renal Cell Carcinoma
Published: June 15th 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
3
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
4
Taking Stock of Immune Effector Cell Therapy Developments in GI Cancers
5
